Interleukin 10 inhibits cytokine production of human AML cells

Annals of Oncology

Volumn 7, Issue 4, 1996, Pages 397-404

  Westermann, F ^a   Kube, D ^a   Haier, B ^a   Bohlen, H ^a   Engert, A ^a   Zuehlsdorf, M ^b   Diehl, V ^a   Tesch, H ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

AML; Cytokines; GM CSF; Interleukin 10

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE MYELOBLASTIC LEUKEMIA; ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; DNA SYNTHESIS; GENE EXPRESSION REGULATION; GROWTH REGULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030018496     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a010607     Document Type: Article

References (43)

1. Young D, Griffin J. Autocrine secretion of GM-CSF in acute myeloblastic leukemia. Blood 1986; 68: 1178-81.
2. Bradbury D, Bowen G, Kozlowski R et al. Endogenous interleukin-1 can regulate the autonomous growth of the blast cells of acute myeloblastic leukemia by inducing autocrine secretion of GM-CSF. Leukemia 1990; 4(1): 44-7.
3. Oster W, Cicco NA, Klein H et al. Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J Clin Invest 1989; 84(2): 451-7.
4. Tobler A, Moser B, Dewald B et al. Constitutive expression of interleukin-8 and its receptor in human myeloid and lymphoid leukemia. Blood 1993; 82(8): 2517-25.
5. Bergamaschi G, Cazzola M, Rosti V et al. Tumor necrosis factor alpha modulates the messenger RNA expression of hematopoietic growth factor genes in fresh blast cells from patients with acute myeloblastic leukemia. Leukemia 1991; 5(10): 886-91.
6. Brach MA, Buhring HJ, Gruss HJ et al. Functional expression of c-kit by acute myelogenous leukemia blasts is enhanced by tumor necrosis factor-alpha through posttranscriptional mRNA stabilization by a labile protein. Blood 1992; 80(5): 1224-30.
7. Broudy VC, Smith FO, Lin N et al. Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor. Blood 1992; 80(1): 60-7.
8. Ferrari S, Grande A, Manfredini R et al. Expression of interleukins 1, 3, 6, stem cell factor and their receptors in acute leukemia blast cells and in normal peripheral lymphocytes and monocytes. Eur J Haematol 1993; 50: 141-8.
9. Budel L, Touw I, Delwel R, Lowenberg B. Granulocyte colony-stimulating factor receptors in human acute myelocytic leukemia. Blood 1989; 74(8): 2668-73.
10. Onetto PN, Aumont N, Haman A et al. Characterization of granulocyte-macrophage colony-stimulating factor receptor on the blast cells of acute myeloblastic leukemia. Blood 1990; 75(1): 59-66.
11. Delwel R, van BC, Lowenberg B, Touw I. Involvement of tumor necrosis factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro. Blood 1992; 80(7): 1798-803.
12. Miyauchi J, Kelleher CA, Yang YC et al. The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood 1987; 70(3): 657-63.
13. Carlesso N, Pregno P, Bresso P et al. Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool. Leukemia 1992; 6 (7): 642-8.
14. Pietsch T, Kyas U, Steffens U et al. Effects of human stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells: Heterogeneity in response and synergy with other hematopoietic growth factors. Blood 1992; 80(5): 1199-206.
15. Delwel R, Dorssers L, Touw I et al. Human recombinant multilineage colony stimulating factor (interleukin-3): Stimulator of acute myelocytic leukemia progenitor cells in vitro. Blood 1987; 70(1): 333-6.
16. Estrov Z, Estey EH, Andreeff M et al. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia. Exp Hematol 1992; 20(5): 558-64.
17. Carter A, Silvian DI, Tatarsky I. Effect of interleukin-1, tumor necrosis factor-alpha, and interferon-alpha on the blast cells of acute myeloblastic leukemia. Am J Hematol 1992; 40(4): 245-51.
18. Moore KW, O'Garra A, de WMR et al. Interleukin-10. Annu Rev Immunol 1993; 11: 165-90.
19. Fiorentino DF, Zlotnik A, Mosmann TR et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147(11): 3815-22.
20. de WMR, Abrams J, Bennett B et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174(5): 1209-20.
21. Rousset F, Garcia E, Defrance T et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 1992; 89(5): 1890-3.
22. Mosmann TR, Moore KW. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 1991; 12(3): 49-53.
23. Rennick D, Hunte B, Dang W et al. Interleukin-10 promotes the growth of megakaryocyte, mast cell, and multilineage colonies: Analysis with committed progenitors and Thy1loSca1+ stem cells. Exp Hematol 1994; 22(2): 136-41.
24. Bennet J, Catovsky D, Daniel M et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 1985; 103: 626-9.
25. Miltenyi S, Müller W, Weichel W, Radbruch A. High gradient magnetic cell separation with macs. Cytometry 1990; 11: 231-8.
26. Hiddemann W, Zuhlsdorf M, Wormann B et al. Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy - a case report on the basis of a clinical phase II trial. Leuk Res 1990; 14(4): 347-52.
27. Platzer C, Ode-Hakim S, Döcke W-D, Volk H-D. Quantitative PCR analysis of cytokine transcription pattern in PBMC after anti-CD3 therapy using two novel multispecific competitor fragments. Transplantation 1994; 58: 264-6.
28. Rodriguez CJ, Beauchemin V, Villeneuve L et al. Coordinate secretion of interleukin-1 beta and granulocyte-macrophage colony-stimulating factor by the blast cells of acute myeloblastic leukemia: Role of interleukin-1 as an endogenous inducer. Blood 1990; 76(8): 1481-9.
29. Akashi K, Harada M, Shibuya T et al. Effects of interleukin-4 and interleukin-6 on the proliferation of CD34+ and CD34-blasts from acute myelogenous leukemia. Blood 1991; 78(1): 197-204.
30. Rogers SY, Bradbury D, Kozlowski R, Russell NH. Evidence for internal autocrine regulation of growth in acute myeloblastic leukemia cells. Exp Hematol 1994; 22(7): 593-8.
31. Wang P, Wu P, Siegel MI et al. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994; 153(2): 811-6.
32. Ernst TJ, Ritchie AR, O'Rourke R, Griffin JD. Colony-stimulating factor gene expression in human acute myeloblastic leukemia cells is posttranscriptionally regulated. Leukemia 1989; 3(9): 620-5.
33. Taetle R, Payne C, Dos SB et al. Effects of transforming growth factor beta 1 on growth and apoptosis of human acute myelogenous leukemia cells. Cancer Res 1993; 53(14): 3386-93.
34. Tessier N, Hoang T. Transforming growth factor beta inhibits the proliferation of the blast cells of acute myeloblatic leukemia. Blood 1988; 72: 159-64.
35. Ferrajoli A, Talpaz M, Zipf TF et al. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha. Leukemia 1994; 8(5): 798-805.
36. Jansen JH, Fibbe WE, Wientjens GJ et al. Inhibitory effect of interleukin-4 on the proliferation of acute myeloid leukemia cells with myelo-monocytic differentiation (AML-M4/M5); the role of interleukin-6. Leukemia 1993; 7(4): 643-5.
37. de VS, Brach MA, Asano Y et al. Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product. Cancer Res 1993; 53(15): 3638-42.
38. Jansen JH, Fibbe WE, Wientjens GJ et al. Interleukin 4 down-regulates the expression of CD14 and the production of interleukin 6 in acute myeloid leukemia cells. Lymphokine Cytokine Res 1991; 10(6): 457-61.
39. Rambaldi A, Torcia M, Dinarello CA et al. Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonist. Leukemia 1993; 7 (Suppl 2): 10-6.
40. Jenkins JK, Malyak M, Arend WP. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1 beta production in human monocytes and neutrophils. Lymphokine Cytokine Res 1994; 13(1): 47-54.
41. Estrov Z, Kurzrock R, Estey E et al. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors. Blood 1992; 79(8): 1938-45.
42. Delwel R, van BC, Salem M et al. Interleukin-1 stimulates proliferation of acute myeloblastic leukemia cells by induction of granulocyte-macrophage colony-stimulating factor release. Blood 1989; 74(2): 586-93.
43. Howard M, Muchamuel T, Andrade S, Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 1993; 177(4): 1205-8.